semaglutide

New Business

Pfizer’s Metsera acquisition to spur Chinese search for next-generation weight-loss drugs

American pharmaceutical giant Pfizer’s up to US$7.3 billion acquisition of next-generation weight loss drugs developer Metsera will encourage more research…

Read More »
New Business

Ascletis Pharma trial shows drug candidate ASC47 boosts weight loss effect of semaglutide

Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the popular anti-obesity…

Read More »
New Business

China has 60 drugs under trial to rival Ozempic in US$150 billion weight-loss market

When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due…

Read More »
New Business

Amanda Bynes starts Ozempic weight loss plan to drop 40 pounds and regain confidence

Amanda Bynes revealed she’s starting Ozempic to lose over 40 pounds, aiming to improve her appearance in paparazzi photos. The…

Read More »
New Business

‘China’s Ozempic’ may vie with Eli Lilly, Novo Nordisk for global weight-loss drug market

The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle…

Read More »
Back to top button